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Granulicatella 
adiacens and 
Early-Onset Sepsis 
in Neonate
To the Editor:  Granulicatella 
and  Abiotrophia, formerly known 
as nutritionally variant streptococci, 
are normal ﬂ  ora of the human upper 
respiratory, gastrointestinal, and 
urogenital tracts (1). G. adiacens has 
been associated with bacteremia and 
endovascular, central nervous system, 
ocular, oral, bone and joint, and 
genitourinary infections (1–4).
Although streptococci are a 
frequent cause of early-onset sepsis 
in newborns, non–group B or D 
streptococci comprise only ≈1% of 
cases of early-onset neonatal sepsis; 
the condition is primarily associated 
with viridans streptococci (5). This 
report describes a male infant with 
early-onset sepsis caused by G. 
adiacens. Molecular genetic studies 
identiﬁ  ed the same organism in ﬂ  ora 
isolated from the maternal cervix, 
which suggests vertical transmission.
After 36 weeks’ gestation, a 
male infant, weighing 2,850 g, was 
born by repeat caesarean section to a 
37-year-old woman who was negative 
for group B streptococcus; she began 
labor without rupture of membranes. 
Apgar scores were 9 and 9 at 1 and 
5 minutes, respectively. Respiratory 
distress developed in the infant within 
an hour of birth. Peripheral blood and 
cerebrospinal  ﬂ   uid (CSF) samples 
were obtained, and intravenous 
ampicillin (150 mg/kg every 12 h) 
and gentamicin (4 mg/kg every 24 
h) were administered. Leukocyte 
count was 27,000/mm3 with 79% 
polymorphonuclear leukocytes and 
2% band forms; platelet count was 
223,000/mm3. CSF cell counts were 3 
leukocytes/mm3 and 18 erythrocytes/
mm3.
Respiratory distress progressed 
rapidly, and at 20 hours of life, 
mechanical ventilation was instituted. 
Chest radiograph demonstrated 
diffuse, bilateral interstitial inﬁ  ltrates 
consistent with pneumonia. Persistent 
pulmonary hypertension was 
diagnosed by echocardiography. 
Peripheral blood culture yielded G. 
adiacens (API 20 STREP, bioMérieux 
Clinical Diagnostics, Durham, NC, 
USA) that was sensitive to vancomycin. 
Repeat blood samples were obtained 
before and after antimicrobial 
drug treatment was changed to 
vancomycin, 10 mg/kg every 12 h, 
and gentamicin, 4 mg/kg every 24 h. 
CSF culture and repeat blood cultures 
had no growth. Vancomycin and 
gentamicin were administered for 14 
days. The patient eventually recovered 
and was discharged after 25 days 
of hospitalization. The biochemical 
identiﬁ  cation  of  G. adiacens in the 
blood culture was conﬁ  rmed by 16S 
rRNA gene sequencing.
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Cervical samples for culturing 
were obtained from the mother 4 
days after delivery. After samples 
were plated on blood and chocolate 
agar, colonies were harvested from 
the primary plates, and pooled 
bacterial DNA was isolated for further 
analyses. A primer pair was designed 
to amplify a 422-bp fragment unique 
to G. adiacens. These primers (sense, 
5′-GGTTTATCCTTAGAAAG
GAGGT-3′, and antisense, 5′-GAGC
ATTCGGTTGGGCACTCTAG-3′) 
were used to amplify G. adiacens 
from DNA prepared from the bacterial 
pools isolated from maternal cervix 
and, as control, from DNA prepared 
from the infant’s blood culture 
isolate. DNA amplicons underwent 
agarose gel electrophoresis with 
ethidium bromide staining and were 
visualized under ultraviolet light. PCR 
ampliﬁ  cation showed DNA amplicons 
for the patient’s blood culture, his 
mother’s cervical swab sample, and 
a positive control but not for negative 
controls (Figure). Capillary nucleotide 
DNA sequence analysis conﬁ  rmed 
all 3 amplicons as G. adiacens (not 
shown).
Nutritionally-variant streptococci 
have been difﬁ  cult to identify because 
they have unique culture requirements, 
they exhibit pleomorphic phenotypic 
features (1), and they demonstrate 
satellitism around colonies of 
other bacteria. This has led to 
misidentiﬁ  cation or nonidentiﬁ  cation 
by using commercially available 
phenotypic testing, prompting the 
recommendation that 16S rRNA gene 
sequencing be used for G. adiacens 
identiﬁ  cation (6).
The Clinical and Laboratory 
Standards Institute does not 
recommend disk-diffusion testing 
to determine the susceptibility of G. 
adiacens to antimicrobial drugs and 
suggests broth microdilution MIC 
testing in cation-adjusted Mueller-
Hinton broth with 2.5%–5% lysed 
horse blood and 0.001% pyridoxine 
hydrochloride (7,8). Under these 
conditions, 55% of G. adiacens isolates 
were susceptible to penicillin, 63% 
were susceptible to ceftriaxone, 96% 
were susceptible to meropenem, and 
100% were susceptible to vancomycin 
(4). A more recent report indicates 
that the resistance of G. adiacens to 
β-lactam and macrolide antimicrobial 
drugs may be increasing (3).
Treatment of G. adiacens infection 
may be difﬁ  cult. In vitro antimicrobial 
drug susceptibility patterns do not 
correlate well with clinical response to 
treatment, and G. adiacens infections 
often respond poorly to antimicrobial 
drug treatment. Higher rates of 
bacteriologic failure and relapse rates 
after treatment have been observed 
for  G. adiacens infection than for 
infections with streptococci and 
other related genera (9). G. adiacens 
endocarditis has been associated with 
a more severe clinical course than 
endocarditis caused by enterococci 
or viridans group streptococci, with 
higher rates of illness and death. On 
the basis of studies demonstrating 
synergy in vitro and in vivo, empiric 
combination therapy with vancomycin 
and an aminoglycoside has been 
suggested until susceptibility data 
are available (10), particularly when 
treating serious conditions such as 
endocarditis (3).
Reports have increased of serious 
infections caused by Granulicatella 
and Abiotrophia, including this report 
of early onset neonatal sepsis due to G. 
adiacens. One recent study described 
8 isolates associated with invasive 
infection in a 4-year period (3). 
Increased awareness and identiﬁ  cation 
of G. adiacens are likely contributing 
to this increased recognition, with 
earlier cases not detected or diagnosed. 
16S rRNA gene sequencing may 
facilitate or conﬁ  rm  Granulicatella 
and Abiotrophia spp. as the etiologic 
agents of infection.
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Figure. PCR ampliﬁ  cation of Granulicatella adiacens DNA. DNA was prepared from the 
bacteria indicated, PCR-ampliﬁ  ed  with  G. adiacens–speciﬁ   c primers, and subjected 
to agarose gel electrophoresis with ethidium bromide staining and ultraviolet light 
visualization. Lane 1, water, negative control; lane 2, G. adiacens–positive control, ATCC 
49175; lane 3, DH5α Escherichia coli–negative control (Invitrogen, Carlsbad, CA, USA) 
18263–012; lane 4, Enterobacter sakazakii–negative control, ATCC BAA-894 (American 
Type Culture Collection, Manassas, VA, USA); lane 5, patient’s blood culture isolate; lane 
6, DNA isolated from a pool of bacteria obtained from the cervix of the patient’s mother. 
DNA amplicons were ampliﬁ  ed only from the positive control, the patient’s blood culture, 
and his mother’s cervical swab specimen. Sequence analysis conﬁ  rmed all 3 amplicons 
as G. adiacens.LETTERS
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Lymphocytic 
Choriomeningitis 
with Severe 
Manifestations, 
Missouri, USA
To the Editor: Lymphocytic 
choriomeningitis virus (LCMV) is an 
arenavirus maintained zoonotically 
in house mice (Mus musculus) and 
may also be carried by pet rodents, 
especially hamsters (1–3). Infection 
of healthy humans usually results in 
nonspeciﬁ  c febrile illness. However, 
LCMV infection can cause severe 
symptoms, including aseptic 
meningitis (4).
Early data suggested <8% of 
central nervous system manifestations 
of viral etiology were caused by 
LCMV (5). In contrast, in a more 
recent study of 91 cases of encephalitis 
among persons with potential rodent 
contact, LCMV was not detected (6). 
We describe 2 recent unrelated LCMV 
infections with central nervous system 
manifestations, which were associated 
with rodent exposures, as a reminder 
that LCMV should be considered 
in cases of aseptic meningitis of 
unknown etiology.
In July 2008, an 89-year-old man 
in Missouri, USA, with a history of 
hypertension received a prescription 
for metolazone and was given 
methotrexate (2.5 mg orally, 3×/wk) 
because of a pharmacy error. Two 
weeks later, he showed confusion, 
speech difﬁ   culty, and had a fever. 
When hospitalized 3 weeks after 
symptom onset, the patient was drowsy 
but able to answer questions and 
had a supple neck, plantar responses 
in extension, and a temperature of 
38.8°C. Methotrexate treatment was 
then stopped.
Routine laboratory test results 
were within reference ranges, with 
the exception of a serum aspartate 
aminotransferase level of 92 U/L 
(reference range 0–37 U/L) and an 
alanine aminotransferase level of 78 
U/L (reference range 0–65 U/L). Two 
blood cultures were sterile, a chest 
radiograph showed cardiomegaly, and 
cranial computed tomography without 
contrast showed moderate cerebral 
atrophy.
The patient was empirically 
given intravenous ceftriaxone (1 g) 
and intravenous azithromycin (500 
mg, 1×/d for 7 days). Two days after 
he was hospitalized, cranial magnetic 
resonance imaging showed mild-
to-moderate, chronic, small vessel 
ischemia and involutional changes. 
Serologic test results for HIV and 
West Nile virus were negative. On the 
fourth hospital day, lumbar puncture 
yielded clear, colorless cerebrospinal 
ﬂ  uid (CSF) containing 1 erythrocyte 
and 98 leukocytes/high-powered ﬁ  eld 
(1% neutrophils, 95% lymphocytes, 
4% monocytes); protein level was 
127 mg/dL (reference range 15–45 
mg/dL), and glucose level was 40 
mg/dL (reference range 43–70 mg/
dL). CSF test results for bacteria, 
cryptococcal antigen, and herpes 
simplex virus (HSV) and PCR 
result for Borrelia burgdorferi were 
negative. CSF and serum submitted 
to the Centers for Disease Control and 
Prevention showed LCMV-speciﬁ  c 
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